1. Home
  2. AEHR vs RVNC Comparison

AEHR vs RVNC Comparison

Compare AEHR & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AEHR
  • RVNC
  • Stock Information
  • Founded
  • AEHR 1977
  • RVNC 1999
  • Country
  • AEHR United States
  • RVNC United States
  • Employees
  • AEHR N/A
  • RVNC N/A
  • Industry
  • AEHR Electrical Products
  • RVNC Biotechnology: Pharmaceutical Preparations
  • Sector
  • AEHR Industrials
  • RVNC Health Care
  • Exchange
  • AEHR Nasdaq
  • RVNC Nasdaq
  • Market Cap
  • AEHR 308.5M
  • RVNC 292.5M
  • IPO Year
  • AEHR 1997
  • RVNC 2014
  • Fundamental
  • Price
  • AEHR $20.61
  • RVNC $3.96
  • Analyst Decision
  • AEHR Hold
  • RVNC Buy
  • Analyst Count
  • AEHR 2
  • RVNC 9
  • Target Price
  • AEHR $12.00
  • RVNC $12.00
  • AVG Volume (30 Days)
  • AEHR 2.2M
  • RVNC 1.9M
  • Earning Date
  • AEHR 07-16-2024
  • RVNC 08-06-2024
  • Dividend Yield
  • AEHR N/A
  • RVNC N/A
  • EPS Growth
  • AEHR 4.00
  • RVNC N/A
  • EPS
  • AEHR 0.52
  • RVNC N/A
  • Revenue
  • AEHR $71,887,000.00
  • RVNC $236,645,000.00
  • Revenue This Year
  • AEHR $2.23
  • RVNC $20.63
  • Revenue Next Year
  • AEHR $4.23
  • RVNC $34.80
  • P/E Ratio
  • AEHR $40.81
  • RVNC N/A
  • Revenue Growth
  • AEHR 14.14
  • RVNC 54.59
  • 52 Week Low
  • AEHR $9.83
  • RVNC $2.30
  • 52 Week High
  • AEHR $54.10
  • RVNC $24.87
  • Technical
  • Relative Strength Index (RSI)
  • AEHR 82.60
  • RVNC 68.64
  • Support Level
  • AEHR $10.55
  • RVNC $2.40
  • Resistance Level
  • AEHR $16.43
  • RVNC $2.75
  • Average True Range (ATR)
  • AEHR 1.17
  • RVNC 0.29
  • MACD
  • AEHR 0.86
  • RVNC 0.19
  • Stochastic Oscillator
  • AEHR 92.68
  • RVNC 79.79

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets are driving additional test requirements, incremental capacity needs, and new opportunities for the company's products in package, wafer level, and singulated die/module level test. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several innovative products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

About RVNC Revance Therapeutics Inc.

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

Share on Social Networks: